A multimodal approach to monitor Extrapyramidal Symptoms.

Problem Addressed

• Trial and Error Approach: After psychiatrists prescribe anti-psychotic treatment, for schizophrenia, bipolar or treatment resistant depression they need to closely monitor for side effects given it is impossible to predict how their patients will respond.

• Time Consuming Monitoring: Assessment of EPS requires a neurological assessment at the end of long psychiatric consultations over sequential assessments. This can delay the optimization of antipsychotic medication doses.

• Subjective Assessments: EPS assessments rely on clinical judgment and expertise of the psychiatrist and are susceptible to human error leading to inconsistent or missed diagnosis of these debilitating symptoms. Clinical recollection of previous assessments conducted often a week apart can be difficult.

The EPSyn Solution

• Monitoring EPSyn can record all 8 EPS symptoms at each assessment enabling the immediate clinical insight and progress from previous reviews.

• Remote Assessments EPSyn would enable assessment over audio-visual link Psychiatric assessments where clinical assessments of EPS symptoms are difficult. Also, patients could monitor their own symptoms using any digital device such as mobile phones, tablets, or desktops.

• Personalized Treatment Plans Assists psychiatrists with patient-centred care given EPSyn will facilitate tailored prescribing based on EPS symptoms and rapid titration of medications if they are not present improving outcomes.

• Clinically Trusted EPSyn monitors minute symptoms that change with antipsychotic medication intake. Its multimodal approach allows for more reliable assessment of sub symptoms of extrapyramidal side effects. With clinically relevant biomarkers, EPSyn provides a robust, reliable assessment for clinicians.